Clemex announces its Financial Results for 2013 The Company ends the year with a net income of 101 302$

Symbol: CXG.A-TSX-V

www.clemex.com

Shares Outstanding: 30,999,810

Montreal, Quebec, August 20th, 2013 --- Clemex Technologies Inc. (TSXV: CXG.A) announces its financial results for Fiscal Year ending April 30th, 2013. The Corporation ends this Fiscal Year with total sales of $5,884,631 in 2013 compared also to $5,939,016 in 2012. Gross margin increased by 2.1% allowing the Company to end this Fiscal Year with a net result of $101,302 compared to $43,467 in 2012.

When asked to comment these results, President and CEO, Clement Forget declared the following: "In 2013, sales in most geographic areas served the Company well again this year. Sales abroad rose by 12.0% while they remained stable at $960,235 in Europe alone, compared to $945,769 in 2012. In United States, sales increased by 4.5%, from $2,449,154 in 2012 to $2,559,710 this year, while total sales for North America fell by 6.6% due to the substantial drop in sales in Canada, which ended at $1,266,814 this year compared to $1,651,814 in 2012. The decrease in sales in Canada is mostly due to a weak manufacturing sector activity and to less microscopes distribution sales in Eastern Canada. Consequently, total Company sales were slightly lower this year when compared to 2012. Finally, the strength of the Canadian dollar, which traded at parity with the U.S. dollar for most of the year, remains a key factor that has been undermining the Company's overall sales as 75% of our sales worldwide are made in US dollars."

Mr. Forget continued: " Various commercial activities were conducted during the 2013 fiscal year to promote the new Haematological analysis instrument. In addition, a private placement was concluded early this year with a German partner and client enabling the Company to raise $1,044,000. These funds will be used mostly to support new medical devices development and marketing activities. In fall of 2012, the Company opened a subsidiary in Martillac, France, located in its French partner facilities, RAL Diagnostics, to be closer to the European market, which provides excellent sales opportunities for Clemex instruments.

Financial Highlights

 ------------------------------------------------------
 |Fiscal year ended       | April 30 th ,| April 30 th|
 |                        |2013          |, 2012      |
 |----------------------------------------------------|
 |                        |              |            |
 |                        |              |            |
 |                        |              |            |
 |                        |    $         |            |
 |                        |              | $          |
 |----------------------------------------------------|
 |Sales                   |5,  884,631   |5, 939,016  |
 |----------------------------------------------------|
 |                        |              |            |
 |----------------------------------------------------|
 |Gross  Margin           |3,  260,235   |3,1 59,697  |
 |----------------------------------------------------|
 |                        |55.4 %        |53.2 %      |
 |----------------------------------------------------|
 |                        |              |            |
 |----------------------------------------------------|
 |Total Operating Expenses|3,1 58,933    |3 ,116,230  |
 |----------------------------------------------------|
 |                        |              |            |
 |----------------------------------------------------|
 |                        |              |            |
 |----------------------------------------------------|
 |Net  Earnings &         |    101 ,302  |     43,467 |
 |Comprehensive  Income   |              |            |
 |----------------------------------------------------|
 |                        |              |            |
 |----------------------------------------------------|
 |E arnings  per share    |      0.003   |   0.002    |
 ------------------------------------------------------

About Clemex Technologies, Inc.

Clemex Technologies Inc. develops, manufactures and markets image analysis systems and software used by quality control and research microscopy laboratories. Clemex customer base spans over many countries in America, Europe, Asia and encompasses major Research and Development Centers, prestigious Universities and large manufacturing industries in various fields including healthcare, automotive, aerospace, raw materials manufacturing, pharmaceuticals, mining and other sectors.

--30--

Clemex Technologies Inc,

800 Guimond,

Longueuil, QC, Canada J4G 1T5,

Contact:

Clement Forget

Tel: [phone]

Email: [e-mail]

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this news release.